127 related articles for article (PubMed ID: 19427201)
1. Semisynthesis and pharmacological activities of Tetrac analogs: angiogenesis modulators.
Bridoux A; Cui H; Dyskin E; Yalcin M; Mousa SA
Bioorg Med Chem Lett; 2009 Jun; 19(12):3259-63. PubMed ID: 19427201
[TBL] [Abstract][Full Text] [Related]
2. Semisynthesis and pharmacological activities of thyroxine analogs: Development of new angiogenesis modulators.
Bridoux A; Cui H; Dyskin E; Schmitzer AR; Yalcin M; Mousa SA
Bioorg Med Chem Lett; 2010 Jun; 20(11):3394-8. PubMed ID: 20434332
[TBL] [Abstract][Full Text] [Related]
3. Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factor.
Mousa SA; Bergh JJ; Dier E; Rebbaa A; O'Connor LJ; Yalcin M; Aljada A; Dyskin E; Davis FB; Lin HY; Davis PJ
Angiogenesis; 2008; 11(2):183-90. PubMed ID: 18080776
[TBL] [Abstract][Full Text] [Related]
4. Tetraidothyroacetic acid (tetrac) and tetrac nanoparticles inhibit growth of human renal cell carcinoma xenografts.
Yalcin M; Bharali DJ; Lansing L; Dyskin E; Mousa SS; Hercbergs A; Davis FB; Davis PJ; Mousa SA
Anticancer Res; 2009 Oct; 29(10):3825-31. PubMed ID: 19846915
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of new analogs of tetraiodothyroacetic acid (tetrac) as novel angiogenesis inhibitors for treatment of cancer.
Rajabi M; Yalcin M; Mousa SA
Bioorg Med Chem Lett; 2018 Apr; 28(7):1223-1227. PubMed ID: 29519736
[TBL] [Abstract][Full Text] [Related]
6. Antiangiogenic activity of deoxoartemisinin derivatives on chorioallantoic membrane.
Jung M; Tak J; Chung WY; Park KK
Bioorg Med Chem Lett; 2006 Mar; 16(5):1227-30. PubMed ID: 16380253
[TBL] [Abstract][Full Text] [Related]
7. Tetraiodothyroacetic acid (tetrac) and nanoparticulate tetrac arrest growth of medullary carcinoma of the thyroid.
Yalcin M; Dyskin E; Lansing L; Bharali DJ; Mousa SS; Bridoux A; Hercbergs AH; Lin HY; Davis FB; Glinsky GV; Glinskii A; Ma J; Davis PJ; Mousa SA
J Clin Endocrinol Metab; 2010 Apr; 95(4):1972-80. PubMed ID: 20133461
[TBL] [Abstract][Full Text] [Related]
8. 5'-O-tritylated nucleoside derivatives: inhibition of thymidine phosphorylase and angiogenesis.
Liekens S; Bronckaers A; Hernández AI; Priego EM; Casanova E; Camarasa MJ; Pérez-Pérez MJ; Balzarini J
Mol Pharmacol; 2006 Aug; 70(2):501-9. PubMed ID: 16675660
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of graveoline and graveolinine derivatives with potent anti-angiogenesis activities.
An ZY; Yan YY; Peng D; Ou TM; Tan JH; Huang SL; An LK; Gu LQ; Huang ZS
Eur J Med Chem; 2010 Sep; 45(9):3895-903. PubMed ID: 20554355
[TBL] [Abstract][Full Text] [Related]
10. The gelatin sponge-chorioallantoic membrane assay.
Ribatti D; Nico B; Vacca A; Presta M
Nat Protoc; 2006; 1(1):85-91. PubMed ID: 17406216
[TBL] [Abstract][Full Text] [Related]
11. Tetraiodothyroacetic acid and tetraiodothyroacetic acid nanoparticle effectively inhibit the growth of human follicular thyroid cell carcinoma.
Yalcin M; Bharali DJ; Dyskin E; Dier E; Lansing L; Mousa SS; Davis FB; Davis PJ; Mousa SA
Thyroid; 2010 Mar; 20(3):281-6. PubMed ID: 20187783
[TBL] [Abstract][Full Text] [Related]
12. Identification of campesterol from Chrysanthemum coronarium L. and its antiangiogenic activities.
Choi JM; Lee EO; Lee HJ; Kim KH; Ahn KS; Shim BS; Kim NI; Song MC; Baek NI; Kim SH
Phytother Res; 2007 Oct; 21(10):954-9. PubMed ID: 17604370
[TBL] [Abstract][Full Text] [Related]
13. The chick embryo and its chorioallantoic membrane (CAM) for the in vivo evaluation of drug delivery systems.
Vargas A; Zeisser-Labouèbe M; Lange N; Gurny R; Delie F
Adv Drug Deliv Rev; 2007 Sep; 59(11):1162-76. PubMed ID: 17870202
[TBL] [Abstract][Full Text] [Related]
14. [Experimental study of Solanum nigrum on inhibiting angiogenesis in chick chorioallantoic membrane].
Xu Y; Pan RL; Chang Q; Qin M; Liu Y; Tang JT
Zhongguo Zhong Yao Za Zhi; 2008 Mar; 33(5):549-52. PubMed ID: 18536381
[TBL] [Abstract][Full Text] [Related]
15. Anti-angiogenic activity of the methanol extract and its fractions of Ulmus davidiana var. japonica.
Jung HJ; Jeon HJ; Lim EJ; Ahn EK; Song YS; Lee S; Shin KH; Lim CJ; Park EH
J Ethnopharmacol; 2007 Jun; 112(2):406-9. PubMed ID: 17428629
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and biological evaluation of bifunctional thyrointegrin inhibitors: new anti-angiogenesis analogs.
Bridoux A; Khan RA; Chen C; Chevé G; Cui H; Dyskin E; Yasri A; Mousa SA
J Enzyme Inhib Med Chem; 2011 Dec; 26(6):871-82. PubMed ID: 21395488
[TBL] [Abstract][Full Text] [Related]
17. TX-2152: a conformationally rigid and electron-rich diyne analogue of FTY720 with in vivo antiangiogenic activity.
Nakayama S; Uto Y; Tanimoto K; Okuno Y; Sasaki Y; Nagasawa H; Nakata E; Arai K; Momose K; Fujita T; Hashimoto T; Okamoto Y; Asakawa Y; Goto S; Hori H
Bioorg Med Chem; 2008 Aug; 16(16):7705-14. PubMed ID: 18678496
[TBL] [Abstract][Full Text] [Related]
18. [Effects of three compounds extracted from Tripterygium wilfordii Hook on angiogenesis in chick chorioallantoic membrane].
Zhu GF; Zhang HQ; Hou AJ; Yang YL; Li QS; Zhang CC
Zhong Xi Yi Jie He Xue Bao; 2007 Sep; 5(5):517-20. PubMed ID: 17854552
[TBL] [Abstract][Full Text] [Related]
19. Anti-angiogenic, antinociceptive and anti-inflammatory activities of Lonicera japonica extract.
Yoo HJ; Kang HJ; Song YS; Park EH; Lim CJ
J Pharm Pharmacol; 2008 Jun; 60(6):779-86. PubMed ID: 18498715
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of anti-angiogenic, anti-inflammatory and antinociceptive activity of coenzyme Q(10) in experimental animals.
Jung HJ; Park EH; Lim CJ
J Pharm Pharmacol; 2009 Oct; 61(10):1391-5. PubMed ID: 19814873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]